Daiichi Sankyo

DSKYF

$41.15B

Large Cap

NASDAQHealthcare🇺🇸North America19.8K employees

Drugs in Pipeline

121

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Mar 17, 2026

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Market Overview

Stock performance and market intelligence

Catalyst Timeline

6 upcoming, 0 past

Phase 2Next

DS-3939a Phase 2 Results Expected

Mar 17, 2026DS-3939a540

Primary completion for DS-3939a trial (NCT05875168) in Advanced Solid Tumor

Source

⭐Phase 3

T-DXd Phase 3 Results Expected

Aug 3, 2026T-DXd50

Primary completion for T-DXd trial (NCT06174987) in Advanced Cancer

Source

⭐Phase 3

Ramucirumab Phase 3 Results Expected

Aug 31, 2026Ramucirumab490

Primary completion for Ramucirumab trial (NCT04704934) in Gastric Cancer, Adenocarcinoma

Source

Phase 2

Carboplatin Phase 2 Results Expected

Sep 30, 2026CS-1008123

Primary completion for Carboplatin trial (NCT06362252) in Extensive Stage-small Cell Lung Cancer

Source

Phase 2

Ifinatamab deruxtecan Phase 2 Results Expected

Sep 30, 2026Ifinatamab deruxtecan123

Primary completion for Ifinatamab deruxtecan trial (NCT06362252) in Extensive Stage-small Cell Lung Cancer

Source

Phase 2

DS-5141b Phase 2 Results Expected

Jan 31, 2027DS-5141b8

Primary completion for DS-5141b trial (NCT04433234) in Duchenne Muscular Dystrophy

Source

AI Predictions & Institutional Flow

Machine learning insights and smart money movement

FDA Submissions

Pending NDA/BLA submissions with predicted PDUFA dates

Drug Pipeline

Clinical development programs and drug candidates

Drug Pipeline

DS-1062a

Phase 3

Non-small Cell Lung Cancer

Chemotherapy

Phase 3

Acute Myeloid Leukemia

Mirogabalin

Phase 3

Diabetic Peripheral Neuropathic Pain

Colesevelam hydrochloride

Phase 3

Type 2 Diabetes

DU-176b (edoxaban)

Phase 3

Venous Thromboembolism

losartan potassium

Phase 3

Essential Hypertension

Olmesartan medoxomil

Phase 3

Atherosclerosis

ofloxacin otic solution 0.3%

Phase 3

Otitis Media

exatecan mesylate

Phase 3

Esophageal Cancer

Pemetrexed

Phase 3

Metastatic Non Small Cell Lung Cancer

Colesevelam HCl

Phase 3

Type 2 Diabetes

DU-176b 30mg

Phase 3

Non-valvular Atrial Fibrillation

Dato-DXd

Phase 3

Urothelial Cancer

gemcitabine hydrochloride

Phase 3

Pancreatic Cancer

Hydrochlorothiazide

Phase 3

Hypertension

warfarin tablets

Phase 3

Stroke

Pexidartinib

Phase 3

Tenosynovial Giant Cell Tumor

Topotecan

Phase 3

Small Cell Lung Cancer

Standard of Care (SOC)

Phase 3

Cardiac Disease

Amlodipine

Phase 3

Hypertension

Welchol

Phase 3

Type 2 Diabetes Mellitus

DU-176b

Phase 3

Venous Thromboembolism

Ramucirumab

Phase 3

Gastric Cancer, Adenocarcinoma

CS-8958

Phase 3

Influenza, Human

olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets

Phase 3

Essential Hypertension

Eplerenone

Phase 3

Essential Hypertension

Eribulin

Phase 3

Breast Cancer

olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets

Phase 3

Essential Hypertension

Pregabalin

Phase 3

Pain Associated With Fibromyalgia

Docetaxel

Phase 3

Non-small Cell Lung Cancer

Standard of Care

Phase 3

Venous Thromboembolism (VTE)

nitrendipine + hydrochlorothiazide, if necessary

Phase 3

Isolated Systolic Hypertension

Pioglitazone

Phase 3

Type 2 Diabetes Mellitus

Carboplatin

Phase 3

Extensive Stage-small Cell Lung Cancer

Metformin HCl tablets and Colesevelam tablets

Phase 3

Type 2 Diabetes Mellitus

Clopidogrel

Phase 3

Atrial Fibrillation

Olmesartan medoxomil 40 mg - Amlodipine 10 mg

Phase 3

Essential Hypertension

VKA-Based Regimen

Phase 3

Atrial Fibrillation

Olmesartan medoxomil tablets low dose

Phase 3

Metabolic Syndrome

T-DM1

Phase 3

HER2-Positive Primary Breast Cancer

15mg DU-176b

Phase 3

Venous Thromboembolism

Colesevelam

Phase 3

Type 2 Diabetes

edoxaban tosylate(DU-176b)

Phase 3

Venous Thromboembolism

Salvage Chemotherapy

Phase 3

AML

olmesartan medoxomil + amlodipine + hydroclororthiazide

Phase 3

Essential Hypertension

enoxaparin sodium

Phase 3

Venous Thromboembolism

Tivantinib

Phase 3

Metastatic Colorectal Cancer

Enoxaparin

Phase 3

Pulmonary Embolism

Denosumab

Phase 3

Osteoporosis

DU-176b 15mg

Phase 3

Venous Thromboembolism

Dalteparin

Phase 3

Venous Thromboembolism (VTE)

olmesartan medoxomil + hydrochlorothiazide

Phase 3

Essential Hypertension

cevimeline hydrochloride

Phase 3

Head and Neck Cancer

T-DXd

Phase 3

Advanced Cancer

Quizartinib

Phase 3

Leukemia

DS-8201a

Phase 3

Neoplasm, Gastrointestinal

Trastuzumab Deruxtecan

Phase 3

Gastric Cancer

CS-3150

Phase 3

Essential Hypertension

Patritumab Deruxtecan

Phase 3

Nonsquamous Non-small Cell Lung Cancer

R-DXd

Phase 3

Solid Cancer

Edoxaban-based Regimen

Phase 3

Atrial Fibrillation

pembrolizumab

Phase 3

Non-small Cell Lung Cancer

Transdermal Patch

Phase 3

Trauma

Rivoglitazone

Phase 3

Type 2 Diabetes

Warfarin

Phase 3

Atrial Fibrillation

Datopotamab Deruxtecan

Phase 3

Metastatic Non Small Cell Lung Cancer

Capecitabine

Phase 3

Breast Cancer

olmesartan medoxomil + hydrochlorothiazide, if necessary

Phase 3

Essential Hypertension

edoxaban

Phase 3

Prevention

DS-5565

Phase 3

Pain Associated With Fibromyalgia

Ifinatamab deruxtecan

Phase 3

Esophageal Squamous Cell Carcinoma

Paclitaxel

Phase 2

Ovarian Cancer Stage IIIC

Patritumab Deruxtecan (Fixed dose)

Phase 2

Non-Small Cell Lung Cancer Metastatic

Carperitide

Phase 2

Heart Failure, Congestive

DS-5565 tablet

Phase 2

Diabetic Peripheral Neuropathy

DS-5670a

Phase 2

Covid19

Raludotatug deruxtecan

Phase 2

Advanced Solid Tumor

CS-1008

Phase 2

Non-small Cell Lung Cancer

HER3-DXd

Phase 2

Advanced Solid Tumor

DU-176b tablets

Phase 2

Atrial Fibrillation

CS-7017

Phase 2

Advanced Non-small Cell Lung Cancer (NSCLC)

SUN13834

Phase 2

Atopic Dermatitis

DS-7011a

Phase 2

Systemic Lupus Erythematosus

piclozotan

Phase 2

Parkinson's Disease

soblidotin

Phase 2

Lung Cancer

CS7017 tablets

Phase 2

Metastatic Non-small Cell Lung Cancer

Temozolomide

Phase 2

Patients With Newly Diagnosed Glioblastoma

DS-1211b

Phase 2

Pseudoxanthoma Elasticum

DS-8500a 25 mg

Phase 2

Type 2 Diabetes Mellitus

5 mg ASB17061

Phase 2

Atopic Dermatitis

VN-0200

Phase 2

Respiratory Syncytial Virus Infections

DS-3939a

Phase 2

Advanced Solid Tumor

DS-8201a 5.4 mg/kg Q3W

Phase 2

Advanced Colorectal Cancer

Valemetostat Tosylate

Phase 2

Adult T-cell Leukemia/Lymphoma

Quizartinib High Dose

Phase 2

Acute Myeloid Leukemia

Pactimibe, CS-505

Phase 2

Coronary Heart Disease

CS7017

Phase 2

Colorectal Cancer

Sitagliptin 100 mg

Phase 2

Type 2 Diabetes Mellitus

DS-1040b

Phase 2

Acute Ischemic Stroke

Warfarin potassium tablets

Phase 2

Atrial Fibrillation

edoxaban tosylate

Phase 2

Deep Vein Thrombosis

DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor

Phase 2

Thrombosis

DS-1001b

Phase 2

WHO Grade II Glioma

AC220

Phase 2

Leukemia, Myeloid, Acute

Compound AC220

Phase 2

Acute Myeloid Leukemia

DS-5141b

Phase 2

Duchenne Muscular Dystrophy

CS-1008 2 mg/kg

Phase 2

Advanced Hepatocellular Carcinoma

Ifinatamab deruxtecan (I-DXd)

Phase 2

Advanced Solid Tumor

SUN13837 injection

Phase 2

Acute Spinal Cord Injury

CS-1008 (humanized anti-DR5 antibody)

Phase 2

Pancreatic Cancer

DJ-927

Phase 2

Colorectal Cancer

U3-1287

Phase 2

NSCLC (Advanced Non-small Cell Lung Cancer)

10mg DS-8500a tablet

Phase 2

Type 2 Diabetes Mellitus

Fludarabine

Phase 2

Acute Myeloid Leukemia

Edoxaban (DU-176b)

Phase 2

Atrial Fibrillation

CS-917

Phase 2

Diabetes Mellitus, Type 2

Pregabalin capsules

Phase 2

Pain

DS3790a

Phase 2

Hematological Malignancies

PLX3397

Phase 2

Hodgkin Lymphoma

Rivoglitazone HCl

Phase 2

Type 2 Diabetes

Aspirin

Phase 2

Peripheral Arterial Disease

Drug Name	Phase	Indication	Designations
DS-1062a	Phase 3	Non-small Cell Lung Cancer	-
Chemotherapy	Phase 3	Acute Myeloid Leukemia	-
Mirogabalin	Phase 3	Diabetic Peripheral Neuropathic Pain	-
Colesevelam hydrochloride	Phase 3	Type 2 Diabetes	-
DU-176b (edoxaban)	Phase 3	Venous Thromboembolism	-
losartan potassium	Phase 3	Essential Hypertension	-
Olmesartan medoxomil	Phase 3	Atherosclerosis	-
ofloxacin otic solution 0.3%	Phase 3	Otitis Media	-
exatecan mesylate	Phase 3	Esophageal Cancer	-
Pemetrexed	Phase 3	Metastatic Non Small Cell Lung Cancer	-
Colesevelam HCl	Phase 3	Type 2 Diabetes	-
DU-176b 30mg	Phase 3	Non-valvular Atrial Fibrillation	-
Dato-DXd	Phase 3	Urothelial Cancer	-
gemcitabine hydrochloride	Phase 3	Pancreatic Cancer	-
Hydrochlorothiazide	Phase 3	Hypertension	-
warfarin tablets	Phase 3	Stroke	-
Pexidartinib	Phase 3	Tenosynovial Giant Cell Tumor	-
Topotecan	Phase 3	Small Cell Lung Cancer	-
Standard of Care (SOC)	Phase 3	Cardiac Disease	-
Amlodipine	Phase 3	Hypertension	-
Welchol	Phase 3	Type 2 Diabetes Mellitus	-
DU-176b	Phase 3	Venous Thromboembolism	-
Ramucirumab	Phase 3	Gastric Cancer, Adenocarcinoma	-
CS-8958	Phase 3	Influenza, Human	-
olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets	Phase 3	Essential Hypertension	-
Eplerenone	Phase 3	Essential Hypertension	-
Eribulin	Phase 3	Breast Cancer	-
olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets	Phase 3	Essential Hypertension	-
Pregabalin	Phase 3	Pain Associated With Fibromyalgia	-
Docetaxel	Phase 3	Non-small Cell Lung Cancer	-
Standard of Care	Phase 3	Venous Thromboembolism (VTE)	-
nitrendipine + hydrochlorothiazide, if necessary	Phase 3	Isolated Systolic Hypertension	-
Pioglitazone	Phase 3	Type 2 Diabetes Mellitus	-
Carboplatin	Phase 3	Extensive Stage-small Cell Lung Cancer	-
Metformin HCl tablets and Colesevelam tablets	Phase 3	Type 2 Diabetes Mellitus	-
Clopidogrel	Phase 3	Atrial Fibrillation	-
Olmesartan medoxomil 40 mg - Amlodipine 10 mg	Phase 3	Essential Hypertension	-
VKA-Based Regimen	Phase 3	Atrial Fibrillation	-
Olmesartan medoxomil tablets low dose	Phase 3	Metabolic Syndrome	-
T-DM1	Phase 3	HER2-Positive Primary Breast Cancer	-
15mg DU-176b	Phase 3	Venous Thromboembolism	-
Colesevelam	Phase 3	Type 2 Diabetes	-
edoxaban tosylate(DU-176b)	Phase 3	Venous Thromboembolism	-
Salvage Chemotherapy	Phase 3	AML	-
olmesartan medoxomil + amlodipine + hydroclororthiazide	Phase 3	Essential Hypertension	-
enoxaparin sodium	Phase 3	Venous Thromboembolism	-
Tivantinib	Phase 3	Metastatic Colorectal Cancer	-
Enoxaparin	Phase 3	Pulmonary Embolism	-
Denosumab	Phase 3	Osteoporosis	-
DU-176b 15mg	Phase 3	Venous Thromboembolism	-
Dalteparin	Phase 3	Venous Thromboembolism (VTE)	-
olmesartan medoxomil + hydrochlorothiazide	Phase 3	Essential Hypertension	-
cevimeline hydrochloride	Phase 3	Head and Neck Cancer	-
T-DXd	Phase 3	Advanced Cancer	-
Quizartinib	Phase 3	Leukemia	-
DS-8201a	Phase 3	Neoplasm, Gastrointestinal	-
Trastuzumab Deruxtecan	Phase 3	Gastric Cancer	-
CS-3150	Phase 3	Essential Hypertension	-
Patritumab Deruxtecan	Phase 3	Nonsquamous Non-small Cell Lung Cancer	-
R-DXd	Phase 3	Solid Cancer	-
Edoxaban-based Regimen	Phase 3	Atrial Fibrillation	-
pembrolizumab	Phase 3	Non-small Cell Lung Cancer	-
Transdermal Patch	Phase 3	Trauma	-
Rivoglitazone	Phase 3	Type 2 Diabetes	-
Warfarin	Phase 3	Atrial Fibrillation	-
Datopotamab Deruxtecan	Phase 3	Metastatic Non Small Cell Lung Cancer	-
Capecitabine	Phase 3	Breast Cancer	-
olmesartan medoxomil + hydrochlorothiazide, if necessary	Phase 3	Essential Hypertension	-
edoxaban	Phase 3	Prevention	-
DS-5565	Phase 3	Pain Associated With Fibromyalgia	-
Ifinatamab deruxtecan	Phase 3	Esophageal Squamous Cell Carcinoma	-
Paclitaxel	Phase 2	Ovarian Cancer Stage IIIC	-
Patritumab Deruxtecan (Fixed dose)	Phase 2	Non-Small Cell Lung Cancer Metastatic	-
Carperitide	Phase 2	Heart Failure, Congestive	-
DS-5565 tablet	Phase 2	Diabetic Peripheral Neuropathy	-
DS-5670a	Phase 2	Covid19	-
Raludotatug deruxtecan	Phase 2	Advanced Solid Tumor	-
CS-1008	Phase 2	Non-small Cell Lung Cancer	-
HER3-DXd	Phase 2	Advanced Solid Tumor	-
DU-176b tablets	Phase 2	Atrial Fibrillation	-
CS-7017	Phase 2	Advanced Non-small Cell Lung Cancer (NSCLC)	-
SUN13834	Phase 2	Atopic Dermatitis	-
DS-7011a	Phase 2	Systemic Lupus Erythematosus	-
piclozotan	Phase 2	Parkinson's Disease	-
soblidotin	Phase 2	Lung Cancer	-
CS7017 tablets	Phase 2	Metastatic Non-small Cell Lung Cancer	-
Temozolomide	Phase 2	Patients With Newly Diagnosed Glioblastoma	-
DS-1211b	Phase 2	Pseudoxanthoma Elasticum	-
DS-8500a 25 mg	Phase 2	Type 2 Diabetes Mellitus	-
5 mg ASB17061	Phase 2	Atopic Dermatitis	-
VN-0200	Phase 2	Respiratory Syncytial Virus Infections	-
DS-3939a	Phase 2	Advanced Solid Tumor	-
DS-8201a 5.4 mg/kg Q3W	Phase 2	Advanced Colorectal Cancer	-
Valemetostat Tosylate	Phase 2	Adult T-cell Leukemia/Lymphoma	-
Quizartinib High Dose	Phase 2	Acute Myeloid Leukemia	-
Pactimibe, CS-505	Phase 2	Coronary Heart Disease	-
CS7017	Phase 2	Colorectal Cancer	-
Sitagliptin 100 mg	Phase 2	Type 2 Diabetes Mellitus	-
DS-1040b	Phase 2	Acute Ischemic Stroke	-
Warfarin potassium tablets	Phase 2	Atrial Fibrillation	-
edoxaban tosylate	Phase 2	Deep Vein Thrombosis	-
DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor	Phase 2	Thrombosis	-
DS-1001b	Phase 2	WHO Grade II Glioma	-
AC220	Phase 2	Leukemia, Myeloid, Acute	-
Compound AC220	Phase 2	Acute Myeloid Leukemia	-
DS-5141b	Phase 2	Duchenne Muscular Dystrophy	-
CS-1008 2 mg/kg	Phase 2	Advanced Hepatocellular Carcinoma	-
Ifinatamab deruxtecan (I-DXd)	Phase 2	Advanced Solid Tumor	-
SUN13837 injection	Phase 2	Acute Spinal Cord Injury	-
CS-1008 (humanized anti-DR5 antibody)	Phase 2	Pancreatic Cancer	-
DJ-927	Phase 2	Colorectal Cancer	-
U3-1287	Phase 2	NSCLC (Advanced Non-small Cell Lung Cancer)	-
10mg DS-8500a tablet	Phase 2	Type 2 Diabetes Mellitus	-
Fludarabine	Phase 2	Acute Myeloid Leukemia	-
Edoxaban (DU-176b)	Phase 2	Atrial Fibrillation	-
CS-917	Phase 2	Diabetes Mellitus, Type 2	-
Pregabalin capsules	Phase 2	Pain	-
DS3790a	Phase 2	Hematological Malignancies	-
PLX3397	Phase 2	Hodgkin Lymphoma	-
Rivoglitazone HCl	Phase 2	Type 2 Diabetes	-
Aspirin	Phase 2	Peripheral Arterial Disease	-

Regulatory & News

Approvals, filings, and latest developments

Regulatory Approvals

DSKYF News